Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 2, 2008, Pages 148.e1-148.e3

  Lavie, Ofer ^a   Gruber, Stephen B ^c   Lejbkowicz, Flavio ^b   Dishon, Sara ^b   Rennert, Gad ^b  

^a CARMEL MEDICAL CENTER   (Israel)

^b CLALIT HEALTH SERVICES   (Israel)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Ashkenazi Jews; colorectal cancer; endometrial cancer; HNFCC; MSH2 A636P founder mutation

Indexed keywords

PROTEIN MSH2;

ADULT; AGED; ARTICLE; CANCER RISK; COLORECTAL CANCER; ENDOMETRIUM CANCER; FAMILIAL CANCER; FEMALE; GENE MUTATION; GYNECOLOGIC CANCER; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR;

EID: 48149095196     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.02.018     Document Type: Article

References (13)

1. Foulkes W.D., Thiffault I., Gruber S.B., et al. The founder mutation MSH2*1906G→C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet 71 (2002) 1395-1412
2. Zauber N.P., Sabbath-Solitare M., Marotta S., et al. Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms. Cancer 104 (2005) 719-729
3. Sun S., Greenwood C.M., Thiffault I., Hamel N., Chong G., and Foulkes W.D. The HNPCC associated MSH2*1906G→C founder mutation probably originated between 1440 CE and 1715 CE in the Ashkenazi Jewish population. J Med Genet 42 (2005) 766-768
4. Lynch H.T., Casey M.J., Shaw T.G., and Lynch J.F. Hereditary factors in gynecologic cancer. Oncologist 3 (1998) 319-338
5. Bermejo J.L., Eng C., and Hemminki K. Cancer characteristics in Swedish families fulfilling criteria for hereditary nonpolyposis colorectal cancer. Gastroenterology 129 (2005) 1889-1899
6. Quehenberger F., Vasen H.F., and van Houwelingen H.C. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet 42 (2005) 491-496
7. Oliveira Ferreira F., Napoli Ferreira C.C., Rossi B.M., et al. Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: an analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry. Fam Cancer 3 (2004) 41-47
8. Cederquist K., Emanuelsson M., Goransson I., et al. Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden. Int J Cancer 109 (2004) 370-376
9. Bianchi F., Rosati S., Belvederesi L., et al. MSH2 splice site mutation and endometrial cancer. Int J Gynecol Cancer 16 (2006) 1419-1423
10. Fidder H.H., Figer A., Geva R., et al. Genetic analyses in consecutive Israeli Jewish colorectal cancer patients. Am J Gastroenterol 100 (2005) 1376-1380
11. Guillem J.G., Moore H.G., Palmer C., et al. A636P testing in Ashkenazi Jews. Fam Cancer 3 (2004) 223-227
12. Aarnio M., Sankila R., Pukkala E., et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81 (1999) 214-218
13. Planck M., Koul A., Fernebro E., et al. hMLH1, hMSH2 and hMSH6 mutations in hereditary non-polyposis colorectal cancer families from southern Sweden. Int J Cancer 83 (1999) 197-202